Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
COLLEGIUM PHARMACEUTICAL, INC (COLL)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.6% stake in Collegium Pharmaceutical Inc. |
02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/30/2023 |
SC 13G/A
| BlackRock Inc. reports a 17.1% stake in COLLEGIUM PHARMACEUTICAL INC |
09/12/2022 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 5.8% stake in Collegium Pharmaceutical, Inc. |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.6% stake in Collegium Pharmaceutical, Inc. |
02/14/2022 |
SC 13G/A
| Camber Capital Management LP reports a 3% stake in Collegium Pharmaceutical, Inc. |
02/14/2022 |
SC 13G/A
| Rubric Capital Management LP reports a 7.5% stake in Collegium Pharmaceutical, Inc. |
02/10/2022 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 10.9% stake in Collegium Pharmaceutical, Inc. |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/28/2022 |
SC 13G/A
| BlackRock Inc. reports a 16.3% stake in COLLEGIUM PHARMACEUTICAL INC |
03/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.7% stake in COLLEGIUM PHARMACEUTICAL INC |
02/04/2020 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.2% stake in Collegium Pharmaceutical, Inc. |
02/04/2020 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 5.3% stake in Collegium Pharmaceutical, Inc. |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G/A
| Partner Fund Management, L.P. reports a 0% stake in Collegium Pharmaceutical, Inc. |
02/14/2018 |
SC 13G/A
| Rock Springs Capital Management LP reports a 5.9% stake in Collegium Pharmaceutical, Inc. |
02/13/2018 |
SC 13G/A
| SECTORAL ASSET MANAGEMENT INC reports a 4.4% stake in COLLEGIUM PHARMACEUTICAL INC |
02/12/2018 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.8% stake in Collegium Pharmaceutical, Inc. |
02/12/2018 |
SC 13G/A
| Longitude Capital Partners, LLC reports a 7.2% stake in Collegium Pharmaceutical, Inc. |
02/06/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 4.6% stake in Collegium Pharmaceutical, Inc. |
|
|
|